Pinned Tweet
Replying to @MIMETAS_3D
@MIMETAS_3D and Pear Bio are collaborating to transform treatment selection in triple-negative breast cancer 🔬Find out more here pearbio.com/wp-content/uploa…
#PearBio #MIMETAS #PrecisionMedicine #BreastCancerResearch #CancerResearch
From all of us at Pear Bio, we wish you a joyful holiday season and a successful year ahead. As we continue to work toward advancing precision oncology, we’re grateful for the support and collaboration of our partners, patients, and community. Here’s to another year of innovation and progress together. Happy Holidays!
Pear Bio attended the Curia Health, Care, and Life Sciences Research Group report launch in Parliament last week, which was run in partnership with @RevvityInc. It was great to hear about how new diagnostics and screening programs can be introduced into the NHS to benefit people across the UK. Transforming Care, Saving Lives #Diagnostics #LifeScience #Research #PearBio @RevvityDX @RevvityLifeSci
Come meet us at San Antonio Breast Cancer Symposium 2024!
Make sure to come along to our poster (P3-01-18) session at 12:30-2:00 pm, Thursday 12th December, where Dr Peter Hall and George de Fraine will discuss Pear Bio’s interim data from our Triple-Negative Breast Cancer trial (NCT05435352), using our image-based predictive functional test to identify optimal patient treatment strategies.#sabcs2024 #breastcancerresearch #pearbio #precisionmedicine
With Thanksgiving just around the corner, the US Pear Bio team have taken part in the @fishersci food drive in support of Boston-area food banks! It is a wonderful opportunity to help those in need and build a stronger community!
#CommunitySupport #GivingBack
We recently posted a pre-print of the interim results from our PEAR-TNBC trial: doi.org/10.1101/2024.10.25.2…
We have ongoing work in metastatic breast and kidney, and brain tumours. We have also done some PPIE work pearbio.com/pear-glio-patien…
All of this is only possible due to the work of the amazing Pear Bio team, our clinical collaborators and, most of all, the patients 16/
Thanks to
@BreastCancerNow and @ImperialNHS for their support
Link to preprint here: doi.org/10.1101/2024.10.25.2…





